首页> 外文期刊>International Journal of Pharmaceutics >Effective protection and controlled release of insulin by cationic beta-cyclodextrin polymers from alginate/chitosan nanoparticles.
【24h】

Effective protection and controlled release of insulin by cationic beta-cyclodextrin polymers from alginate/chitosan nanoparticles.

机译:阳离子β-环糊精聚合物从藻酸盐/壳聚糖纳米颗粒中有效保护和控制胰岛素释放。

获取原文
获取原文并翻译 | 示例
       

摘要

In an alginate/chitosan nanoparticle system, insulin was protected by forming complexes with cationic beta-cyclodextrin polymers (CPbetaCDs), which were synthesized from beta-cyclodextrin (beta-CD), epichlorohydrin (EP) and choline chloride (CC) through a one-step polycondensation. Due to the electrostatic attraction between insulin and CPbetaCDs, as well as the assistance of its polymeric chains, CPbetaCDs could effectively protect insulin under simulated gastrointestinal conditions. The nanoparticles have their mean size lower than 350 nm and can load insulin with the association efficiency (AE) up to 87%. It is notable that the cumulative insulin release in simulated intestinal fluid was significantly higher (40%) than that without CPbetaCDs (18%) because insulin was mainly retained in the core of the nanoparticles and well protected against degradation in simulated gastric fluid. Far-UV circular dichroism analysis also corroborated the preservation of insulin structure during the nanoparticle preparation and release process.
机译:在藻酸盐/壳聚糖纳米粒子系统中,胰岛素通过与阳离子β-环糊精聚合物(CPbetaCD)形成复合物而受到保护,该聚合物由β-环糊精(β-CD),表氯醇(EP)和氯化胆碱(CC)合成而成。分步缩聚。由于胰岛素和CPbetaCD之间的静电吸引以及其聚合物链的帮助,CPbetaCD在模拟胃肠道条件下可以有效保护胰岛素。纳米粒子的平均粒径小于350 nm,可以以高达87%的缔合效率(AE)负载胰岛素。值得注意的是,在模拟肠液中的累积胰岛素释放量(40%)比没有CPbetaCDs的累积释放量(18%)要高得多,这是因为胰岛素主要保留在纳米颗粒的核心中,并且在模拟胃液中得到很好的保护,免受降解。远紫外圆二色性分析还证实了纳米颗粒制备和释放过程中胰岛素结构的保留。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号